Cargando…
Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of Clostridium difficile Infection Associated with Antibacterial Drug Exposure
Antibacterial drug exposure (ADE) is a well-known potential risk factor for Clostridium difficile infection (CDI), but it remains controversial which certain antibacterial drugs are associated with the highest risk of CDI occurrence. To summarize CDI risk associated with ADE, we reviewed the CDI rep...
Autores principales: | Li, Dongxuan, Song, Yi, Bai, Zhanfeng, Xi, Xin, Liu, Feng, Zhang, Yang, Qin, Chunmeng, Du, Dan, Du, Qian, Liu, Songqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376141/ https://www.ncbi.nlm.nih.gov/pubmed/37508205 http://dx.doi.org/10.3390/antibiotics12071109 |
Ejemplares similares
-
Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023) -
Antibacterial effect of Manuka honey on Clostridium difficile
por: Hammond, Eric N, et al.
Publicado: (2013) -
Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile
por: Yang, Huan, et al.
Publicado: (2020) -
Isobavachalcone From Cullen corylifolium Presents Significant Antibacterial Activity Against Clostridium difficile Through Disruption of the Cell Membrane
por: Liu, Xi-Wang, et al.
Publicado: (2022) -
Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis
por: Bai, Yuanyuan, et al.
Publicado: (2017)